The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis by.

Slides:



Advertisements
Similar presentations
Rick Allen.  Leukaemia involves widespread bone marrow involvement and a presence in peripheral blood.  Lymphoma’s arise in discrete tissue masses (commonly.
Advertisements

MANTLE CELL Lymphoma (WITH EMPHASIS ON THE gi TRACT)
Hodgkin lymphomas Monirath Hav, MD, PhD fellow Pathology Department Ghent University Hospital Adapted from WHO Classification of Tumours of Haematopoietic.
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications by Elias Campo, Steven H. Swerdlow, Nancy L.
Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations by Susan Price, Pamela A. Shaw, Amy Seitz, Gyan Joshi, Joie.
Chapter 15.  Immunological tolerance is defined as unresponsiveness to an antigen that is induced by previous exposure to that antigen  Antigens that.
How I treat enteropathy-associated T-cell lymphoma by Antonio Di Sabatino, Federico Biagi, Paolo G. Gobbi, and Gino R. Corazza Blood Volume 119(11):
Dodo Case 10 A 48 year old male initially presented with spinal cord compression and a paraspinal mass. He received local radiation therapy. Eight months.
Cellular origin of lymphoma
Characterization and treatment of chronic active Epstein- Barr virus disease: a 28-year experience in the United States by Jeffrey I. Cohen, Elaine S.
Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells by Jonathan M. Irish,
Cellular origin of lymphoma
M1 – Immunology CYTOKINES AND CHEMOKINES March 26, 2009 Ronald B
Copyright © 2014 American Medical Association. All rights reserved.
Nodular lymphocyte-predominant Hodgkin lymphoma. A
Figure 5. Histological specimen of sentinel lymph node after second excision. (A) Histological examination of in situ follicular lymphoma in sentinel lymph.
MLAB Hematology Keri Brophy-Martinez
Chemokine Receptor Expression on Neoplastic and Reactive T Cells in the Skin at Different Stages of Mycosis Fungoides  Tilmann Kallinich, J. Marcus Muche,
Blockade of Glucocorticoid-Induced Tumor Necrosis Factor–Receptor-Related Protein Signaling Ameliorates Murine Collagen-Induced Arthritis by Modulating Follicular.
High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia by Marco Herling, Kaushali.
Expression of CD10 by Human T Cells That Undergo Apoptosis Both In Vitro and In Vivo by Giovanna Cutrona, Nicolò Leanza, Massimo Ulivi, Giovanni Melioli,
CD3−CD56+ Non-Hodgkin's Lymphomas With an Aggressive Behavior Related to Multidrug Resistance by Bernard Drénou, Thierry Lamy, Laurence Amiot, Olivier.
Rituximab plus CHOP (R-CHOP) overcomes bcl-2—associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)‏ by Nicolas.
by Kumudha Balakrishnan, William G. Wierda, Michael J
European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals.
In the absence of IGF-1 signaling, IFN-γ suppresses human malignant T-cell growth by Laura Conti, Gabriella Regis, Angela Longo, Paola Bernabei, Roberto.
Mutation Analysis of the Rearranged Immunoglobulin Heavy Chain Genes of Marginal Zone Cell Lymphomas Indicates an Origin From Different Marginal Zone B.
CD6 Ligation Modulates the Bcl-2/Bax Ratio and Protects Chronic Lymphocytic Leukemia B Cells From Apoptosis Induced by Anti-IgM by Lyda M. Osorio, Angelina.
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States by Jeffrey I. Cohen, Elaine S. Jaffe,
Relationship of p53, bcl-2, and Tumor Proliferation to Clinical Drug Resistance in Non-Hodgkin's Lymphomas by Wyndham H. Wilson, Julie Teruya-Feldstein,
Figure 7 Defects in apoptosis
Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells by Aleksandar Petlickovski,
Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy by Mark P. Chao, Chad Tang, Russell K. Pachynski,
Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities.
IL-6 and MYC collaborate in plasma cell tumor formation in mice
A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions.
by Herbert Bosshart, and Ruth F. Jarrett
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells by Sergey Krysov, Samantha Dias, Alex Paterson, C.
Chronic neutropenia mediated by Fas ligand
by Parisa Asvadi, Zohra Ahmadi, and Beng H. Chong
Figure 3.Low power view revealed a bluish mass involving the intestinal wall (H-E, x40). Scattered benign histiocytes were present in the diffuse tumor.
Cathepsin-B-dependent apoptosis triggered by antithymocyte globulins: a novel mechanism of T-cell depletion by Marie-Cécile Michallet, Frederic Saltel,
BCL-6 Protein Expression in Human Peripheral T-Cell Neoplasms Is Restricted to CD30+ Anaplastic Large-Cell Lymphomas by Antonino Carbone, Annunziata Gloghini,
by Sara Tedoldi, Jennifer C
WHO-EORTC classification for cutaneous lymphomas
Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids.
HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8–positive plasmablastic lymphoma by Nicolas Dupin, Tim L.
CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells by Maria Pia Pistillo,
by Eleanor J. Molloy, Amanda J. O'Neill, Julie J
The BH3-mimetic GX synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak by Patricia Pérez-Galán, Gaël.
Volume 126, Issue 5, Pages (May 2004)
C-FLIP confers resistance to FAS-mediated apoptosis in anaplastic large-cell lymphoma by Mauricio P. Oyarzo, L. Jeffrey Medeiros, Coralyn Atwell, Marianna.
Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells by Jonathan M. Irish,
B lymphocytes: how they develop and function
Patient-derived xenografts of low-grade B-cell lymphomas demonstrate roles of the tumor microenvironment by W. Richard Burack, Janice M. Spence, John P.
CXCR5 and ICOS expression identifies a CD8 T-cell subset with TFH features in Hodgkin lymphomas by Kieu-Suong Le, Patricia Amé-Thomas, Karin Tarte, Françoise.
Richard M. Siegel, MD, PhD, Thomas A. Fleisher, MD 
Volume 98, Issue 1, Pages (July 1999)
Defective negative regulation of Toll-like receptor signaling leads to excessive TNF-α in myeloproliferative neoplasm by Hew Yeng Lai, Stefan A. Brooks,
Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL by Monika Pilichowska, Stefania Pittaluga,
Volume 125, Issue 2, Pages (August 2003)
Targeting ubiquitin-activating enzyme induces ER stress–mediated apoptosis in B-cell lymphoma cells by Scott Best, Taylor Hashiguchi, Adam Kittai, Nur.
Histological and immunohistochemical evaluation of primary central nervous system lymphoma. Histological and immunohistochemical evaluation of primary.
Histopathology and bcl-2 immunohistochemistry of in situ follicular lymphoma.(A-B) Low-power view of H&E-stained (A) and bcl-2–stained (B) sections showing.
by Matthew S. Painschab, Kate D
David A Schwarz, Carol D Katayama, Stephen M Hedrick  Immunity 
Biology and treatment of Richter syndrome
Lamellarin D induces cell death through a Fas-independent pathway.
SY-1425 induces maturation in RARA-high AML
Presentation transcript:

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis by Stephen E. Straus, Elaine S. Jaffe, Jennifer M. Puck, Janet K. Dale, Keith B. Elkon, Angela Rösen-Wolff, Anke M. J. Peters, Michael C. Sneller, Claire W. Hallahan, Jin Wang, Roxanne E. Fischer, Christine M. Jackson, Albert Y. Lin, Caroline Bäumler, Elke Siegert, Alexander Marx, Akshay K. Vaishnaw, Tamara Grodzicky, Thomas A. Fleisher, and Michael J. Lenardo Blood Volume 98(1):194-200 July 1, 2001 ©2001 by American Society of Hematology

Structure of the TNFRSF6 (APT1) gene encoding the Fas protein, showing locations of the mutations associated with ALPS and lymphoma.Exon 9 is expanded to show α-helical regions of the intracellular death domain.67 Mutations are newly described or previously... Structure of the TNFRSF6 (APT1) gene encoding the Fas protein, showing locations of the mutations associated with ALPS and lymphoma.Exon 9 is expanded to show α-helical regions of the intracellular death domain.67 Mutations are newly described or previously reported from NIH (indicated by black symbols),8 11 15 44 Cornell University, New York (indicated by gray symbols),10 26 or Dresden, Germany (indicated by white symbols).30 Mutations seen in individuals with lymphoma are indicated by boxed symbols. Stephen E. Straus et al. Blood 2001;98:194-200 ©2001 by American Society of Hematology

Histopathology and immunopathology of lymphomas in ALPS patients Histopathology and immunopathology of lymphomas in ALPS patients.(A) T-cell and histiocyte-rich B-cell lymphoma diagnosed in patient 3-II-3. Histopathology and immunopathology of lymphomas in ALPS patients.(A) T-cell and histiocyte-rich B-cell lymphoma diagnosed in patient 3-II-3. Large polylobated tumor cells, which stained for CD20, are seen in a background of T lymphocytes and histiocytes. (B-D) Nodular lymphocyte-predominant Hodgkin disease diagnosed in patient 3-II-1. (B) A rim of epithelioid granulomas surrounds a large nodule containing neoplastic cells. (C) A single polylobated L&H cell is identified in a background of small lymphocytes. (D) A CD20+ L&H cell is rosetted by a rim of CD20− T cells. Numerous CD20+ small B cells are present in the background. (E) Burkitt lymphoma presenting as an omental mass in patient 26-II-4. Tumor cells are moderate in size with clumped chromatin and basophilic nucleoli. A prominent starry sky is present. (F) Tumor cells uniformly express CD20. The growth fraction was 100% with MIB-1 (Ki-67) staining. Identical histologic and immunophenotypic features were seen in lymphoma involving small bowel in patient 30-III-2. (G) An unusual form of follicular lymphoma was diagnosed in patient 55-II-1. Neoplastic cells surround hyalinized and possibly regressed follicular remnants. (H) CD20 immunohistochemistry emphasized follicular pattern. (I) The neoplastic cells are moderate in size with clumped chromatin. (J) A follicle-center origin for tumor cells is supported by Bcl-6 immunohistochemistry, which selectively stains the neoplastic cells within the follicles. Original magnification (A), ×400; (B), ×60; (C), ×400; (D), ×400; (E), ×400; (F), ×400; (G), ×200; (H), ×200; (I), ×400; and (J), ×250. Stephen E. Straus et al. Blood 2001;98:194-200 ©2001 by American Society of Hematology

Resistance of lymphoma cells to Fas-induced apoptosis Resistance of lymphoma cells to Fas-induced apoptosis.Cell suspensions prepared from a lymphomatous lymph node from NIH ALPS proband 55 were subjected to apoptosis induction either via antibody cross-linking of Fas or by 5 μg/mL staurosporine that induces a... Resistance of lymphoma cells to Fas-induced apoptosis.Cell suspensions prepared from a lymphomatous lymph node from NIH ALPS proband 55 were subjected to apoptosis induction either via antibody cross-linking of Fas or by 5 μg/mL staurosporine that induces apoptosis by the mitochondrial pathway. The percentages of cells dying are compared with the results with resting lymph node (RLN) cells from patient 55, with cells from a family 17 ALPS patient, with Jurkat T-lymphoma cells, with KK124B Burkitt lymphoma cells, and with normal human tonsil cells. Flow cytometry analysis showed that lymphoma cells from patient 55 were of large size and exhibited B-cell markers and that both the lymphoma cells and the smaller resting lymphocytes expressed normal levels of the Fas receptor on the cell surface. Stephen E. Straus et al. Blood 2001;98:194-200 ©2001 by American Society of Hematology